Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 8215834, 11 pages
http://dx.doi.org/10.1155/2016/8215834
Research Article

Thyroid Hormones, Autoantibodies, Ultrasonography, and Clinical Parameters for Predicting Thyroid Cancer

1Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
2Department of Endocrinology, Chengdu First People’s Hospital, Chengdu 610041, China

Received 19 January 2016; Accepted 23 March 2016

Academic Editor: Diego Russo

Copyright © 2016 Lin-zheng He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. L. Mazzaferri, “Thyroid cancer in thyroid nodules: finding a needle in the haystack,” The American Journal of Medicine, vol. 93, no. 4, pp. 359–362, 1992. View at Publisher · View at Google Scholar · View at Scopus
  2. G. H. Tan and H. Gharib, “Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging,” Annals of Internal Medicine, vol. 126, no. 3, pp. 226–231, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Noguchi, H. Yamashita, S. Uchino, and S. Watanabe, “Papillary microcarcinoma,” World Journal of Surgery, vol. 32, no. 5, pp. 747–753, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Kimura, A. Van Keymeulen, J. Golstein, A. Fusco, J. E. Dumont, and P. P. Roger, “Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models,” Endocrine Reviews, vol. 22, no. 5, pp. 631–656, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Samadi, P. Loo, R. Mukerji et al., “A novel HSP90 modulator with selective activity against thyroid cancers in vitro,” Surgery, vol. 146, no. 6, pp. 1196–1207, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Ariga, T. Nedachi, M. Akahori et al., “Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells,” Biochemical Journal, vol. 348, no. 2, pp. 409–416, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. D. S. Cooper, G. M. Doherty, B. R. Haugen et al., “Management guidelines for patients with thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 16, no. 2, pp. 109–142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Perros, K. Boelaert, S. Colley et al., “Guidelines for the management of thyroid cancer,” Clinical Endocrinology, vol. 81, supplement 1, pp. 1–122, 2014. View at Publisher · View at Google Scholar
  9. K. Boelaert, J. Horacek, R. L. Holder, J. C. Watkinson, M. C. Sheppard, and J. A. Franklyn, “Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 11, pp. 4295–4301, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. A. Polyzos, M. Kita, Z. Efstathiadou et al., “Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules,” Journal of Cancer Research and Clinical Oncology, vol. 134, no. 9, pp. 953–960, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. R. Haymart, D. J. Repplinger, G. E. Leverson et al., “Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 3, pp. 809–814, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Fiore, T. Rago, M. A. Provenzale et al., “Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role,” Endocrine-Related Cancer, vol. 16, no. 4, pp. 1251–1260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Fiore and P. Vitti, “Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 4, pp. 1134–1145, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. K. W. Kim, Y. J. Park, E. H. Kim et al., “Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis,” Head and Neck, vol. 33, no. 5, pp. 691–695, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. R. Castro, R. P. Espiritu, R. S. Bahn et al., “Predictors of malignancy in patients with cytologically suspicious thyroid nodules,” Thyroid, vol. 21, no. 11, pp. 1191–1198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. C. Frates, C. B. Benson, P. M. Doubilet et al., “Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 9, pp. 3411–3417, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Fiore, T. Rago, M. A. Provenzale et al., “L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients,” Endocrine-Related Cancer, vol. 17, no. 1, pp. 231–239, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Fiore, T. Rago, F. Latrofa et al., “Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine,” Endocrine-Related Cancer, vol. 18, no. 4, pp. 429–437, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Jonklaas, H. Nsouli-Maktabi, and S. J. Soldin, “Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer,” Thyroid, vol. 18, no. 9, pp. 943–952, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Gul, D. Ozdemir, A. Dirikoc et al., “Are endogenously lower serum thyroid hormones new predictors for thyroid malignancy in addition to higher serum thyrotropin?” Endocrine, vol. 37, no. 2, pp. 253–260, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Rago, E. Fiore, M. Scutari et al., “Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease,” European Journal of Endocrinology, vol. 162, no. 4, pp. 763–770, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Zafon, G. Obiols, J. A. Baena, J. Castellví, B. Dalama, and J. Mesa, “Preoperative thyrotropin serum concentrations gradually increase from benign thyroid nodules to papillary thyroid microcarcinomas then to papillary thyroid cancers of larger size,” Journal of Thyroid Research, vol. 2012, Article ID 530721, 4 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. E. S. Kim, D. J. Lim, K. H. Baek et al., “Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules,” Thyroid, vol. 20, no. 8, pp. 885–891, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. S. Kim, B. J. Lee, J. C. Lee et al., “Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience,” Endocrine, vol. 39, no. 3, pp. 259–265, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Mariotti, P. Caturegli, P. Piccolo, G. Barbesino, and A. Pinchera, “Antithyroid peroxidase autoantibodies in thyroid disease,” Journal of Clinical Endocrinology and Metabolism, vol. 71, no. 3, pp. 661–669, 1990. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Rago, G. Di Coscio, C. Ugolini et al., “Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy,” Clinical Endocrinology, vol. 67, no. 3, pp. 363–369, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Azizi and C. D. Malchoff, “Autoimmune thyroid disease: a risk factor for thyroid cancer,” Endocrine Practice, vol. 17, no. 2, pp. 201–209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Zhang, H. Li, Q.-H. Ji et al., “The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease,” BMC Cancer, vol. 12, article 610, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Konturek, M. Barczyński, W. Wierzchowski, M. Stopa, and W. Nowak, “Coexistence of papillary thyroid cancer with Hashimoto thyroiditis,” Langenbeck's Archives of Surgery, vol. 398, no. 3, pp. 389–394, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Okayasu, M. Fujiwara, Y. Hara, Y. Tanaka, and N. R. Rose, “Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma: a study of surgical cases among Japanese, and white and African Americans,” Cancer, vol. 76, no. 11, pp. 2312–2318, 1995. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Guarino, M. D. Castellone, E. Avilla, and R. M. Melillo, “Thyroid cancer and inflammation,” Molecular and Cellular Endocrinology, vol. 321, no. 1, pp. 94–102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Wirtschafter, R. Schmidt, D. Rosen et al., “Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis,” Laryngoscope, vol. 107, no. 1, pp. 95–100, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Unger, M. Ewart, B. Y. Wang, L. Gan, D. S. Kohtz, and D. E. Burstein, “Expression of p63 in papillary thyroid carcinoma and in hashimoto's thyroiditis: a pathobiologic link?” Human Pathology, vol. 34, no. 8, pp. 764–769, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. S. D. Larson, L. N. Jackson, T. S. Riall et al., “Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway,” Journal of the American College of Surgeons, vol. 204, no. 5, pp. 764–773, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Crile Jr., “Struma lymphomatosa and carcinoma of the thyroid,” Surgery Gynecology and Obstetrics, vol. 147, no. 3, pp. 350–352, 1978. View at Google Scholar · View at Scopus
  36. L. E. Holm, H. Blomgren, and T. Lowhagen, “Cancer risks in patients with chronic lymphocytic thyroiditis,” The New England Journal of Medicine, vol. 312, no. 10, pp. 601–604, 1985. View at Publisher · View at Google Scholar · View at Scopus
  37. E.-K. Kim, S. P. Cheong, Y. C. Woung et al., “New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid,” American Journal of Roentgenology, vol. 178, no. 3, pp. 687–691, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. J. K. Hoang, K. L. Wai, M. Lee, D. Johnson, and S. Farrell, “US features of thyroid malignancy: pearls and pitfalls,” Radiographics, vol. 27, no. 3, pp. 847–860, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. W.-J. Moon, L. J. So, H. L. Jeong et al., “Benign and malignant thyroid nodules: US differentiation—multicenter retrospective study,” Radiology, vol. 247, no. 3, pp. 762–770, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. D. S. Cooper, G. M. Doherty, B. R. Haugen et al., “Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 19, no. 11, pp. 1167–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. S. S. Ahn, E.-K. Kim, D. R. Kang, S.-K. Lim, J. Y. Kwak, and M. J. Kim, “Biopsy of thyroid nodules: comparison of three sets of guidelines,” American Journal of Roentgenology, vol. 194, no. 1, pp. 31–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. R. S. Sippel, D. M. Elaraj, E. Khanafshar et al., “Tumor size predicts malignant potential in Hürthle cell neoplasms of the thyroid,” World Journal of Surgery, vol. 32, no. 5, pp. 702–707, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Raparia, S. K. Min, D. R. Mody, R. Anton, and M. Amrikachi, “Clinical outcomes for suspicious category in thyroid fine-needle aspiration biopsy patient's sex and nodule size are possible predictors of malignancy,” Archives of Pathology and Laboratory Medicine, vol. 133, no. 5, pp. 787–790, 2009. View at Google Scholar · View at Scopus
  44. N. Besic, M. Sesek, B. Peric, J. Zgainar, and M. Hocevar, “Predictive factors of carcinoma in 327 patients with follicular neoplasm of the thyroid,” Medical Science Monitor, vol. 14, no. 9, pp. R459–R467, 2008. View at Google Scholar · View at Scopus
  45. M. Kihara, M. Hirokawa, H. Masuoka et al., “Evaluation of cytologically benign solitary thyroid nodules by ultrasonography: a retrospective analysis of 1877 cases,” Auris Nasus Larynx, vol. 40, no. 3, pp. 308–311, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Anil, A. Hegde, and F. H. V. Chong, “Thyroid nodules: risk stratification for malignancy with ultrasound and guided biopsy,” Cancer Imaging, vol. 11, no. 1, pp. 209–223, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. C. R. McHenry, E. S. Huh, and R. N. Machekano, “Is nodule size an independent predictor of thyroid malignancy?” Surgery, vol. 144, no. 6, pp. 1062–1069, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. E. Papini, R. Guglielmi, A. Bianchini et al., “Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-doppler features,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 5, pp. 1941–1946, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. R. M. Walsh, J. C. Watkinson, and J. Franklyn, “The management of the solitary thyroid nodule: a review,” Clinical Otolaryngology and Allied Sciences, vol. 24, no. 5, pp. 388–397, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. W.-W. Zhan, P. Zhou, J.-Q. Zhou, S.-Y. Xu, and K.-M. Chen, “Differences in sonographic features of papillary thyroid carcinoma between neck lymph node metastatic and nonmetastatic groups,” Journal of Ultrasound in Medicine, vol. 31, no. 6, pp. 915–920, 2012. View at Google Scholar · View at Scopus
  51. A. S. Kabaker, M. E. Tublin, Y. E. Nikiforov et al., “Suspicious ultrasound characteristics predict BRAFV600E-positive papillary thyroid carcinoma,” Thyroid, vol. 22, no. 6, pp. 585–589, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. M.-S. Ko, K. S. Jeong, Y. K. Shong, G. Y. Gong, J. H. Baek, and J. H. Lee, “Collapsing benign cystic nodules of the thyroid gland: sonographic differentiation from papillary thyroid carcinoma,” American Journal of Neuroradiology, vol. 33, no. 1, pp. 124–127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. G. F. W. Scheumann, O. Gimm, G. Wegener, H. Hundeshagen, and H. Dralle, “Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer,” World Journal of Surgery, vol. 18, no. 4, pp. 559–567, 1994. View at Publisher · View at Google Scholar · View at Scopus
  54. S.-M. Chow, S. C. K. Law, J. K. C. Chan, S.-K. Au, S. Yau, and W.-H. Lau, “Papillary microcarcinoma of the thyroid—prognostic significance of lymph node metastasis and multifocality,” Cancer, vol. 98, no. 1, pp. 31–40, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. H. J. Steinkamp, M. Cornehl, N. Hosten, W. Pegios, T. Vogl, and R. Felix, “Cervical lymphadenopathy: ratio of long- to short-axis diameter as a predictor of malignancy,” British Journal of Radiology, vol. 68, no. 807, pp. 266–270, 1995. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Khanna, A. D. Sharma, S. Khanna, M. Kumar, and R. C. Shukla, “Usefulness of ultrasonography for the evaluation of cervical lymphadenopathy,” World Journal of Surgical Oncology, vol. 9, article 29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. C. R. McHenry, P. G. Walfish, and I. B. Rosen, “Non-diagnostic fine needle aspiration biopsy: a dilemma in management of nodular thyroid disease,” American Surgeon, vol. 59, no. 7, pp. 415–419, 1993. View at Google Scholar · View at Scopus
  58. W. Raber, K. Kaserer, B. Niederle, and H. Vierhapper, “Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients,” Thyroid, vol. 10, no. 8, pp. 709–712, 2000. View at Publisher · View at Google Scholar · View at Scopus
  59. E. K. Alexander, S. Hurwitz, J. P. Heering et al., “Natural history of benign solid and cystic thyroid nodules,” Annals of Internal Medicine, vol. 138, no. 4, pp. 315–318, 2003. View at Publisher · View at Google Scholar · View at Scopus